Fairer Winds For Pharma? OSI Banner Year Fueled By Tarceva Approval, Iressa News
Executive Summary
OSI Pharmaceuticals is finding that a competitor's surprise misfortune may be even more advantageous than receiving widely-anticipated good news for itself.